borderline significantp = 0.16
302 (AK) days, p = 0.97), mice with an additional oncogenic mutation of Trp53 (AKPr mice) had a borderline significant shorter median survival (186 days, p = 0.16).
302 (AK) days, p = 0.97), mice with an additional oncogenic mutation of Trp53 (AKPr mice) had a borderline significant shorter median survival (186 days, p = 0.16).